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ABSTRACT
Conventional approaches to target labelling for
expression microarray analysis typically require
relatively large amounts of total RNA, a serious
limitation when the sample available is small. Here
we explore the cycle-dependent ampli®cation char-
acteristics of Template-Switching PCR and validate
its use for microarray target labelling. TS-PCR iden-
ti®es up to 80% of the differentially expressed genes
identi®ed by direct labelling using 30-fold less input
RNA for the ampli®cation, with the equivalent of
1000-fold less starting material being used for each
hybridisation. Moreover, the sensitivity of micro-
array experiments is increased considerably, allow-
ing the identi®cation of differentially expressed
transcripts below the level of detection using
targets prepared by direct labelling. We have also
validated the ®delity of ampli®cation and show that
the ampli®ed material faithfully represents the start-
ing mRNA population. This method outperforms
conventional labelling strategies, not only in terms
of sensitivity and the identi®cation of differentially
expressed genes, but it is also faster and less
labour intensive than other ampli®cation protocols.
INTRODUCTION
Microarray technology is delivering profound insights into
numerous biological processes. Conventional target labelling
protocols however, need relatively large amounts (>20 mg) of
input total RNA per hybridisation. The need for replicate
hybridisations increases the demand for RNA further still. In
circumstances where the sample available is limited, such as
in the case of clinically derived material or the need to focus
the analysis on speci®c cell populations, there is often too little
RNA available to perform the analysis using conventional
labelling strategies.
In order to circumvent this issue, a signi®cant amount of
effort has been focused on approaches to reduce the RNA
requirement per hybridisation through the use of either signal
or RNA ampli®cation technologies. Various approaches to
signal ampli®cation have been described and in some cases
have brought down the requirement for RNA by as much as
10-fold (1±5), but these protocols are problematic and
expensive to perform. Furthermore, even with this improve-
ment, the amounts of RNA required are still often unobtain-
able. With respect to RNA ampli®cation strategies, T7
polymerase in vitro transcription (IVT) is currently the most
commonly used and well documented ampli®cation protocol
(6). Although successful in signi®cantly reducing RNA
requirements, IVT-based ampli®cation procedures have
several notable shortcomings. Protocols are time-consuming,
labour-intensive and costly. Moreover, if RNA is very
limiting, consecutive rounds of IVT ampli®cation are required
to generate suf®cient material for hybridisation (7,8), which
further adds to the complexity of the procedure and reduces
the linearity of the ampli®cation.
PCR has a number of potential advantages; it is faster, more
cost effective and offers an almost unlimited degree of
ampli®cation. A number of variations on PCR labelling have
been described (9±12), including those using template
switching PCR (TS-PCR) (13,14), commercialised by
Clontech in their SMART PCR cDNA synthesis kit (15±17).
While these studies demonstrated the potential of the
approach, they focused little attention on the relationship
between the degree of ampli®cation and the ®delity of the
ampli®ed material with respect to the starting mRNA popu-
lation. It has however been these very understandable
concerns about the faithfulness of PCR ampli®cation that
have held back the widespread adoption of the approach by the
microarray community. We therefore set out to perform the
®rst in depth examination of the potential for TS-PCR to
generate high ®delity labelled target for expression microarray
analysis.
MATERIALS AND METHODS
Construction of spotted oligonucleotide arrays
Oligonucleotide probes (60mers; Sigma-Genosys) represent-
ing 9332 human sequence clusters were rearrayed into 384-
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well plates at a concentration of 200 ng/ml, and spotted onto
Surmodic 3-D link slides (Motorola) using a MicroGrid TAS
arrayer (BioRobotics). Control oligonucleotides (50mers)
representing ubiquitously expressed or tissue-speci®c genes,
as well as bacterial spike sequences, were also incorporated
onto the array. Following printing, slides were processed
according to the manufacturer's protocol.
Cell culture, RNA isolation and quality assessment
This study employed three distinct human cell lines, two of
glioma origin, T98G and U118, and one of breast cancer
origin, SKOU3. All cell lines were cultured in F12 medium
containing 10% FCS (Gibco-BRL). When 80% con¯uent, the
cultures were harvested, pelleted and washed with PBS. RNA
was extracted using guanidine isothiocyanate ultracentrifuga-
tion as described previously (18). RNA concentration and
integrity were assessed spectrophotometrically and on an
Agilent Bioanalyzer 2100.
Preparation of directly labelled cDNA targets
Directly labelled cDNA targets were prepared as follows.
300 pmol of oligo(dT)17V primer were mixed with 30 mg of
total RNA in a ®nal volume of 15.4 ml. The reaction mixture
was incubated at 70°C for 10 min, quenched on ice for 2 min
and then 14.6 ml of labelling mix [13 ®rst strand cDNA
synthesis buffer (Invitrogen), 10 mM DTT, 0.5 mM each of
dATP, dGTP and dTTP, 0.2 mM dCTP, 3 ml Cy3- or
Cy5-dCTP (Amersham Pharmacia Biotech) and 2 ml
Superscript II (Invitrogen)] were added and the reaction
incubated at 42°C for 2 h in the dark. Labelled cDNA was
puri®ed on an AutoSeq G-50 column (Amersham Pharmacia
Biotech); the Cy5 and Cy3 samples were then pooled and
precipitated with EtOH.
Preparation of ampli®ed labelled cDNA targets
TS-PCR ampli®ed ds cDNA was prepared using the SMART
cDNA synthesis kit (BD Clontech) as follows. Total RNA
(1000±50 ng) was mixed with 10 pmol 3¢ SMART CDS
primer IIA (5¢-AAGCAGTGGTATCAACGCAGAGTAC-
T30VN-3¢) and 10 pmol template switching primer [5¢-
d(AAGCAGTGGTATCAACGCAGAGTACGC)r(GGG)-3¢]
in a volume of 5 ml; the reaction mixture was incubated at
70°C for 2 min and then quenched on ice for 2 min. The
following reagents were then added, 2 ml 53 ®rst strand
buffer, 1 ml 20 mM DTT, 1 ml 10 mM dNTPs and 1 ml
PowerScript RT, and the reaction incubated at 42°C for 1 h. A
2 ml aliquot of the ®rst strand cDNA was then used as
template for the second strand ampli®cation reaction. The
following reagents were added, 80 ml dH2O, 10 ml 103
Advantage 2 PCR Buffer (BD Clontech), 2 ml 10 mM dNTPs,
4 ml PCR primer (5¢-AAGCAGTGGTATCAACGCAGAGT-
3¢) and 2 ml 503 Advantage 2 polymerase mix and the
reaction mixture was subjected to the following cycling
programme, 95°C for 1 min and then a variable number of
cycles (5±21) of 95°C for 5 s, 65°C for 5 s and 68°C for 6 min.
Labelled target was prepared as follows: 21 ml of ds cDNA
was mixed with 20 ml of 2.53 random prime reaction buffer
(Invitrogen), incubated at 100°C for 5 min and placed on ice.
The following reagents were added, 5 ml of Low-C dNTP mix
(5 mM dATP, 5 mM dGTP, 5 mM dTTP, 2 mM dCTP), 3 ml
Cy3 or Cy5-dCTP (Amersham) and 40 U Klenow polymerase
and the reaction incubated at 37°C for 2 h in the dark. The
reaction was terminated with the addition of 5 ml stop buffer
(Invitrogen) and the labelled products were puri®ed as
described for the directly labelled targets above.
Spotted oligonucleotide microarray hybridisation and
scanning
For each set of conditions tested, triplicate hybridisations were
performed. These included a dye-swap hybridisation, which
was always performed in the same dye direction. Labelled
targets were resuspended in 35 ml of hybridisation buffer (40%
formamide, 53 SSC, 53 Denhardt's solution, 1 mM sodium
pyrophosphate, 50 mM Tris pH 7.4, 0.1% SDS), denatured at
95°C for 5 min, incubated at 50°C for 5 min and then
centrifuged at 13 000 r.p.m. for 5 min before being applied to
an array. Hybridisations were performed under a coverslip at
50°C in a humidi®ed oven for 16 h. Following hybridisation,
slides were washed twice in 23 SSC for 10 min, twice in 0.13
SSC/0.1% SDS for 5 min and ®nally twice in 0.13 SSC for
5 min; all washes were performed at RT. After washing,
slides were dried by centrifugation at 1000 r.p.m. for 2 min,
and then scanned on an Agilent G256B scanner. Raw image
data were extracted using Imagene Version 5.0 software
(BioDiscovery).
Validation of TS-PCR ampli®cation using Affymetrix
Genechip technology
T98G and U118 cell line total RNA (7 mg) were used to
synthesise biotin-labelled cRNA, which were then each
hybridised onto Affymetrix HG-U133A arrays according to
the manufacturer's instructions. Following hybridisation and
washing, the arrays were scanned using a GeneArray scanner
(Agilent Technologies). Data analysis was performed using
Microarray Analysis Suite (MAS) Version 5.0 software
(Affymetrix).
Data analysis
Features whose mean signal intensity was less than four times
the standard deviation of the local background pixel intensity
were automatically ¯agged in Imagene. Manual ¯agging was
also used to remove irregularities such as scratches and dust
particles. Data were imported into GeneSpring 5.0 (Silicon
Genetics) for analysis. Normalisation was performed using the
Loess algorithm. Unless otherwise stated, only genes with data
in all three replicates of all conditions examined were used
(`present'). Genes with no data above background data in any
of the three replicates for each condition were called `absent'.
Identi®cation of genes with ratios statistically signi®cantly
different from 1 was performed using a t-test at the 95%
con®dence level.
For assessment of the effects of ampli®cation on the
representation of transcripts of different lengths, transcript
lengths corresponding to each feature on our array were
queried against the EMBL and REFSEQ databases using the
program Infoseq. This program is part of the freely available
open source software package, European Molecular Biology
Open Software Suite (EMBOSS, http://www.hgmp.mrc.ac.uk/
Software/EMBOSS). All data will be made available on the
HGMP Microarray website and through ArrayExpress.
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RESULTS
General ampli®cation characteristics of TS-PCR
Experiments were designed to examine the ampli®cation
characteristics of TS-PCR (13,14), in comparison to direct
labelling of RNA using reverse transcriptase, by microarray
analysis of labelled cDNA generated by these approaches. For
all assays described here, 1 mg of total RNA was used for ®rst
strand synthesis. This represents an amount of RNA obtain-
able in the majority of studies and under the conditions
described here is suf®cient to generate enough labelled cDNA
for a minimum of 20 hybridisations. However, the technique
can also be used with lower amounts of input RNA and has
been employed successfully with as little as 50 ng total RNA
(data not shown). The entire protocol, from RNA to hybrid-
isation, can be performed in a single day and is readily
compatible with high throughput plate formats.
TS cDNA synthesis was initially designed as a method
maximising full-length transcript representation in cDNA
library construction (13,19). Electrophoretic characterisation
of TS-PCR generated cDNA showed detectable transcript
sizes ranging from 0.2 to 7 kb (Fig. 1A). This is as expected for
mammalian full-length cDNA and is in agreement with
previously published observations (13,17,20).
Effect of cycle number on representation of ampli®ed
cDNA
Total T98G and U118 glioma cell line RNA (1 mg) was
reverse transcribed and aliquots of ®rst strand cDNA were
ampli®ed through 13, 15, 17, 19 or 21 cycles of long distance
PCR. Spectrophotometric assessment of the overall mass of
the ampli®ed material at different cycle numbers indicated
that ampli®cation was exponential up to 17 PCR cycles, with
the mass of ampli®ed material plateauing after 19 cycles.
Similar ®ndings have also been found by analysis of a number
of individual transcripts by quantitative PCR on ampli®ed
material (data not shown).
To test the ®delity of ampli®cation, we sought to validate
TS-PCR using high-density oligonucleotide microarrays.
Experiments were designed to investigate whether expression
differences identi®ed by conventional direct labelling of RNA
(`true differentials') were maintained with hybridisations
using Klenow-labelled TS-PCR ampli®ed cDNA. Initially,
T98G and U118 cell line RNAs were used. Both are
glioma-derived adherent cell lines with very similar genomic
aberrations (K.Ichimura, personal communication). All
hybridisations were performed in triplicate and included a
dye-reversal hybridisation. In all cases the dye reversal was in
the same orientation for each experiment. Qualitatively,
hybridisations using labelled TS-PCR products were charac-
terised by higher signal intensities in both channels, which
directly correlates with the increased mass of cDNA available
for labelling, particularly at higher cycle numbers (Fig. 2A).
Associated with this is an increase in the number of features
with an observed signal above background (Fig. 2B).
Moreover, correlation coef®cients between replicate hybrid-
isations were seen to increase with ampli®cation number
(Fig. 2C). Direct labelling demonstrated the poorest correl-
ation between replicate hybridisations (Fig. 2C). For statistical
analyses, only genes present in all three replicates of all direct
labelling and ampli®ed target hybridisations were used. The
percentage of differentially expressed genes identi®ed by
direct labelling that were also identi®ed by TS-PCR
hybridisations was seen to increase with cycle number,
reaching a maximum (76%) after 19 cycles, then falling off
(Fig. 2D, Table 1).
Log ratio values of the genes identi®ed as being signi®-
cantly differentially expressed between samples decreased
Figure 1. (A) Electrophoretic assessment of T98G cDNA, produced by 13 cycles of TS-PCR. Ladder sizes shown in kb. Bands designated `m' correspond to
markers introduced into the assay. (B) Effect of transcript length on ef®ciency of ampli®cation. Transcripts were grouped into 12 categories by length, ranging
from 0.5 to over 10 kb. For each SMART cycle and for direct labelling, the number of genes in each transcript category was expressed as a percentage of the
total number of genes present.
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with ampli®cation cycle number (data not shown). Principal
component analysis (PCA) corroborated these results
(Fig. 2E). Compression effects of PCR ampli®cation on log
ratios have been observed previously (10).
An additional set of hybridisations was performed compar-
ing T98G glioma versus SKOU3 breast cancer cell line RNAs
(Fig. 3). As with the T98G versus U118 experiment, TS-PCR
consistently produced more reproducible data, with less noise
and higher signal intensities than direct labelling (Fig. 3). The
`true' differential identi®cation success for the ampli®ed
target was comparable using these more distinct RNA
samples, with 80% of direct labelling differentials being
successfully identi®ed by 15 cycle ampli®ed material com-
pared to 71% in the U118 versus T98G experiment at the same
cycle number.
This study (Fig. 1A) and those by others (13) have
suggested that TS-PCR generates high molecular weight
transcripts. We wished to corroborate the effect of ampli®ca-
tion on the representation of genes with different transcript
lengths in the microarray data. The genes represented on the
oligonucleotide array were categorised according to their
transcript length. For both direct labelling and TS-PCR, the
percentage of total genes that fell into each transcript length
category remained remarkably constant demonstrating no bias
towards the ampli®cation of short transcripts (Fig. 1B).
A number of genes were seen as being discordant between
hybridisations using ampli®ed and non-ampli®ed cDNA
preparations. Some genes were consistently above background
in TS-PCR but found to be absent in direct labelling
hybridisations. The number of TS-PCR-speci®c genes above
background was seen to increase with cycle number (Fig. 2B).
In both the T98G versus U118 and T98G versus SKOU3
hybridisations, genes that were present only in hybridisations
using TS-PCR ampli®ed material were almost entirely clus-
tered at the low intensity, high variance end of the data in the
direct incorporation dataset. This observation is consistent
with increased assay sensitivity with ampli®cation.
In addition, a number of genes were identi®ed as being
differentially expressed only in hybridisations performed
using TS-PCR ampli®ed cDNA and not in direct labelling
hybridisations. In the majority of these cases, while the
discordant gene set failed to reach statistical signi®cance in
directly labelled hybridisations, its expression pattern showed
a trend in the correct direction, that is genes found to be up-
regulated by TS-PCR have ratios >1 by direct labelling and
vice versa (data not shown).
In an attempt to validate genes that were identi®ed as
differentially expressed in TS-PCR but not direct labelling
hybridisations, the expression pro®les of T98G and U118 total
RNA were also assessed using Affymetrix HG-U133A
GeneChips (Table 1). Of those genes found to be differentially
expressed only by TS-PCR, approximately 70% showed
concordance in the direction of differential expression in the
Affymetrix dataset (Table 1).
Figure 2. Summary of trends across ampli®cation cycle number. (A) Mass
of cDNA used per labelling reaction. Means from two distinct ampli®cations
shown. For comparison, the theoretical maximum mass of cDNA produced
by reverse transcription of 30 mg of total RNA is also shown. The value was
calculated assuming 100% ef®ciency of the reverse transcription reaction.
Ampli®cation-fold and direct labelling cDNA mass estimation were
calculated assuming mRNA as 1% of total RNA used. (B) Number of genes
consistently above background in all three replicate hybridisations
performed per condition. (C) Correlation coef®cients between replicate
hybridisations. Genes with replicate signal intensities that were less than
5-fold apart were used. This removed 44 genes (from 3925 in total)
from direct labelling and none from the SMART ampli®ed replicate sets.
(D) Percent of direct labelling (`true') differentials successfully identi®ed by
hybridisations using SMART ampli®ed cDNA. (E) Plot of the ®rst principal
component of the entire dataset. All genes present in any of the replicate
hybridisations using SMART and direct labelling were included in the
analysis. The pattern de®ned by the ®rst principal component re¯ects genes
whose ratio values converge towards one with increasing ampli®cation cycle
number.
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Table 1. Assessment of differentials identi®ed by TS-PCR as compared with direct incorporation and
Affymetrix GeneChip
No. of
differentialsa
Overlap
(%)b
Unique to
TS-PCRc
Present on
U133d
Differential on U133e
Up-regulated Down-regulated
Direct labelling 393 ± ± ± ± ±
13 cycles 684 249 (63.4) 435 260 68.4 67.1
15 cycles 775 278 (70.7) 497 294 67.8 68.9
17 cycles 906 286 (72.8) 620 367 66.7 69.0
19 cycles 1011 300 (76.3) 711 409 65.9 67.6
21 cycles 800 260 (66.2) 530 307 70.4 69.1
aTotal no. of differentials identi®ed by each protocol/cycle number.
bOverlap between direct incorporation and TS-PCR differential data sets.
cDifferentials unique to TS-PCR.
dNumber of unique TS-PCR differentials represented on Affymetrix HG-U133A chip and called present by
MAS 5 software.
ePercent concordance in direction of differential expression between genes found to be differentially expressed
by TS-PCR and represented and present on Affymetrix HG-U133A chips.
Figure 3. (A) T98G versus SKOU3 hybridisations. Detail from an array hybridised with direct labelled cDNA using 30 mg of starting total RNA per colour
(left) and from the same section of an array hybridised with ampli®ed cDNA after 15 cycles of PCR using the equivalent of 40 ng total RNA per colour
(right). (B) Superimposition of log intensity scatter-plots from T98G versus SKOU3 hybridisations generated by direct labelling (blue scatter) and 15 cycle
PCR ampli®ed cDNA (pink scatter) target preparations. Mean intensity values derived from three separate hybridisations are shown. Only genes with negative
background-subtracted intensity values were excluded from the plot.
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DISCUSSION
Ampli®cation strategies represent the most promising
approach currently being pursued to reduce the microgram
quantities of RNA required to perform a single microarray
hybridisation. At present, the most commonly used ampli®-
cation method is IVT (6). This method uses T7 RNA
polymerase ampli®cation where quantitative biases within
the ampli®ed RNA population are generally accepted to be
kept within an acceptable range. However, the protocol does
have a number of drawbacks: it is time consuming, labour
intensive and costly. In addition, a single round of ampli®-
cation is not usually suf®cient when dealing with sub-
microgram quantities of RNA. Another feature of IVT is a
shortening of the ampli®ed cRNA compared to the parent
mRNA population, and this 3¢ bias is further accentuated by
multiple rounds of IVT (7,21).
Other proposed ampli®cation protocols utilise PCR-based
exponential ampli®cation (9±12,15). The widespread adoption
of such protocols has been held back by the concern that the
exponential nature of the PCR step will introduce a serious
representational bias into the ampli®ed material and thereby
prevent quantitative analyses. Balanced against this question
of linearity are the potential advantages PCR-based methods
might offer over IVT-based ampli®cation protocols, namely
speed, ease of use and applicability to high-throughput
situations. One PCR-based ampli®cation method that has
been used to generate labelled targets for microarray analyses
is TS-PCR (15±17). However, none of these studies has
systematically addressed the relationship between degree of
ampli®cation and the ®delity of the ampli®ed cDNA.
In the present study, we have used a two-colour high density
oligonucleotide microarray platform to examine this crucial
question. Spectrophotometric and electrophoretic assessment
of the ampli®ed cDNA product indicates that, under the
conditions described here, the ampli®cation process is expo-
nential up to 17 cycles and generates products with a size
distribution between 0.2 and 7 kb. In addition, the distribution
of transcript sizes identi®ed by microarray analysis reveals no
evidence that ampli®cation favours the detection of shorter
transcripts even at high cycle numbers. Therefore, in contrast
to IVT methods, 5¢ representation is likely to be good in the
TS-PCR ampli®ed cDNA allowing much greater ¯exibility
when designing array probes for the detection of alternative
splice variants.
From a qualitative perspective, arrays performed using
ampli®ed targets were consistently brighter than those
hybridised with directly labelled targets. Quantitatively this
is re¯ected in an increase in the number of features called
present. Indeed, there is a strong correlation between fold
ampli®cation and the number of features called present, at
least across the exponential phase of the reaction. This is
almost certainly due to the increased mass of cDNA produced
by PCR that is available for labelling. A signi®cant proportion
of total cellular mRNA is comprised of low abundance
transcripts (22), the majority of which are expressed at levels
below the sensitivity of current direct labelling protocols. The
increased sensitivity offered by TS-PCR ampli®cation brings
this pool of RNAs into the detection range of microarray
technology. In disagreement with Puskas et al. (16), we
observed a much better correlation between replicate arrays
hybridised with ampli®ed targets compared to those hybrid-
ised with direct labelled targets. The correlation between
replicates increases with the degree of ampli®cation; this
increased precision most probably re¯ects the increase in
signal intensities seen with increasing degrees of ampli®ca-
tion. One difference between the protocol described here and
that of Puskas et al., is that they used Taq polymerase to label
their PCR products whereas we used random primed Klenow
labelling. In our experience, Taq polymerase gives much
poorer incorporation of Cy dyes, resulting in much weaker
signal intensities and as a result higher inter-array variability.
An examination of differentially expressed genes revealed a
high concordance between those identi®ed using ampli®ed
and unampli®ed targets, indicating that relative transcript
abundance is preserved during ampli®cation. The level of
concordance between genes identi®ed as differentially expres-
sed reported in the present study is in good agreement with
those reported previously for both IVT and other PCR-based
ampli®cation protocols (10,16,23). Greater concordance was
observed with increasing cycle number, which most likely
re¯ects the decreased variance between replicates associated
with increased signal intensity. Analysis of the set of genes
only identi®ed as differentially expressed using direct
labelling revealed no correlation with signal intensity, tran-
script length or failure to amplify. In fact, no gene identi®ed as
present using directly labelled targets was consistently absent
in hybridisations performed with ampli®ed targets. In contrast,
the tighter replicate data generated with ampli®ed targets
provides a good explanation for genes only identi®ed as
differentially expressed using ampli®ed targets. Ampli®ed
targets demonstrate a compression in the ratio values of
differentially expressed genes, a feature that has been reported
previously for exponentially ampli®ed targets (10).
Compression, however, does not affect the ability to identify
differentially expressed genes. It is associated with lower
variance between replicates and as a consequence improved
statistical resolution of differentials. Indeed, as shown in
Figure 2, cycle numbers at which the observed compression
was greatest showed the highest rates of `true' differential
identi®cation.
TS-PCR is both the fastest (RNA to hybridisation per-
formed easily within a day) and lowest cycle number PCR
ampli®cation protocol described to date. It is entirely 96-well
compatible and bypasses the requirement for complex
enzymatic steps, lengthy incubations and laborious puri®ca-
tions. Furthermore, each ampli®cation generates a cDNA
library for every sample processed, providing a resource for
future hybridisations and/or quantitative PCR validation. In
contrast to other PCR protocols (10) and IVT ampli®cation
methods (23), this method is capable of producing high
molecular weight transcripts that allow the design of
microarray probes complementary to sequences distal to
their 3¢ end.
The development of better labelling strategies is essential to
unlock the power of microarray technology for studies where
sample is limiting. This is crucial when using clinically
derived samples, puri®ed cell populations, microdissected
material and single cells. These data suggest that whilst
exponential ampli®cation using TS-PCR affects relative
transcript abundances, these effects are minimal over a wide
range of PCR cycles and do not inhibit the ability to identify
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differentially expressed genes. Furthermore, enhanced signal
intensities generate data that is signi®cantly more reproducible
and allow sampling of genes whose expression is below the
sensitivity of direct labelling protocols. We suggest TS-PCR
offers an economical, reproducible and robust alternative to
other labelling technologies and recommend its use for
microarray target preparation.
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